The GLP-1 Lab

by GLP-1 SOS

Meet GLP-1 SOS

Category: Food noise, appetite & plateau

How a GLP-1 changes food noise and appetite, and what to do when weight loss stalls.

  • Is a plateau normal on a GLP-1 (and when)?

    Is a plateau normal on a GLP-1 (and when)?

    The short answer

    Yes. Every long GLP-1 trial shows the same shape: fast loss in the first months, a gentler slope, then a flattening in the later months as the body settles at a new weight with a lower energy spend. A stall is a flat line with a cause you can name, and that is the one to take to your prescriber.

    At GLP-1 SOS, the message that arrives around month five reads the same way every time: stuck for three weeks and afraid it has stopped working. Here is what the trial curves and the body’s own accounting say.

    Same scale, different cause

    A plateau or a stall

    A plateau: expected

    • Flat for four weeks or more
    • After months of steady loss
    • Same dose, no missed shots
    • Eating and moving about the same
    • Clothes still fitting looser

    A stall: find the cause

    • A dose step that never happened
    • Missed or late shots
    • Snacks and drinks crept back
    • New medication, short sleep, more alcohol
    • Eating past the fullness signal
    • Two flat weeks called a plateau

    On a slowed gut, water and stool can hide a fat change for two weeks.

    What is actually happening

    STEP 1 followed adults on Wegovy 2.4 mg for 68 weeks, 16 of them escalation, for an average loss of 14.9 percent. SURMOUNT-1 followed adults on Zepbound 5, 10 or 15 mg for 72 weeks, up to 20 of them escalation, for average losses of 15 to 20.9 percent. In both, the weight curves fall steeply through the first months, slope more gently through the middle, and level off in the final months. Nobody kept losing at the early rate.

    Weight is defended, not just carried. The brain treats a range of body weight as its set point and pushes back against loss with hunger and a lower energy spend. A GLP-1 lowers the weight the brain is willing to defend by acting on its appetite circuits; it does not remove the defense. As the gap between where you are and where the body will now sit closes, loss slows.

    A smaller body burns fewer calories at rest and with every step, so the meals that produced a deficit in month two produce a smaller one in month eight. Studies of moderate weight loss find that resting energy expenditure falls somewhat more than the lost tissue predicts, an effect called adaptive thermogenesis, though its size varies widely between people. Meanwhile intake creeps: small meals start to feel normal and the extra bites stop registering. The deficit narrows from both sides until it closes; that closing point is the plateau.

    Lab note

    The scale stops when intake and spend meet. Arithmetic, not failure.

    A plateau is flat for weeks at a stable maintenance dose, after months of loss, with eating and movement unchanged. A stall is flat because something changed: a skipped dose step, missed shots, snacks and drinks that came back, a new medication, short sleep, more alcohol, or eating past the fullness signal. On a slowed gut, water, salt and stool can also hide a fat change for two weeks, so a short flat line is often not a plateau at all.

    Inside the plateau

    What happens when the weight stabilizes

    1

    Smaller body, smaller burn

    Every pound gone is a pound you no longer carry or feed.

    2

    Resting burn drops a little extra

    Adaptive thermogenesis: the body spends less than the lost tissue alone predicts.

    3

    Appetite quietly recalibrates

    Small meals start to feel normal; the extra bites stop registering.

    4

    The deficit closes

    When intake and spend meet, the weight holds. That is the plateau.

    What to do

    1. Give it four weeks before you name it. Weigh once a week, same morning, same conditions. Two flat weeks on a slowed gut is usually water and stool; four flat weeks at a stable dose is a plateau.
    2. Measure something other than weight. Waist at the navel once a month, and one pair of pants you use as a gauge. Fat can keep leaving while the scale holds.
    3. Audit the creep for three days. Write down every bite and every drink, including the tastes while cooking and the wine. The appetite effect makes small meals feel like nothing, and the extras add up quietly.
    4. Put protein first at every meal. Muscle is the part of your resting burn you can keep. Eat the protein before the rest of the plate, and do not let a small appetite turn into a carbohydrate-only day.
    5. Add movement you were not doing last month. A ten-minute walk after each meal and two short strength sessions a week raise the spend side of the equation, and muscle is what protects the resting burn as weight falls.
    6. Check sleep and alcohol. Short sleep raises hunger the next day, and alcohol adds calories while loosening the fullness signal. Both are common, quiet causes of a stall.
    7. Bring a one-page log to your prescriber. Dose, the date of each step, weekly weights, and the three-day audit. Ask whether you are on a maintenance dose or still stepping up, whether there is a step left, and whether this is the weight where you hold. Never change the dose on your own.

    When to call your doctor

    Call your prescriber the same day if:

    • The flat line comes with vomiting you cannot control
    • You have severe stomach pain
    • You feel faint when you stand
    • You have not been able to eat or drink normally for more than a day
    • Your weight is rising quickly with swelling in your legs
    • Your urine is dark and scarce
    • Your mood has dropped in a way that worries you

    A flat line is normal. A flat line with new symptoms is not.

    GLP-1 SOS

    From the people behind the Lab

    You do not have to figure this out alone.

    GLP-1 SOS is the daily companion made for life on a GLP-1. Plain answers like this one, a support team that replies to real questions from real people, and daily formulas like GLP-1 SOS Daily Gut Relief, designed around the side effects that come with the medication. The GLP-1 Lab is our free education arm: no login, no paywall, no hype. Side effects are part of the road. Suffering through them is not.

    Meet GLP-1 SOS

    Questions people also ask

    When do you plateau on Ozempic or Wegovy?

    There is no fixed week. In STEP 1 the average curve fell steeply through the first months at 2.4 mg, slowed through the middle of the 68 weeks and leveled off toward the end. Where your own curve flattens depends on your starting weight, your dose and how much intake creeps back. Months of loss followed by a flat stretch is the pattern, not a sign of a fault.

    How do you break a plateau on a GLP-1?

    First confirm it is one: four flat weeks at a stable maintenance dose. Then work the two sides of the deficit. Intake: a three-day audit, protein first, liquid calories and alcohol out. Spend: walk after meals and add two short strength sessions a week. If those change nothing over another month, bring the log to your prescriber and discuss the dose together.

    Does increasing the dose fix a plateau?

    Sometimes, and only your prescriber can decide. The Wegovy label lists 1.7 mg and 2.4 mg as maintenance doses and allows an increase to 7.2 mg only for adults who have tolerated 2.4 mg for at least four weeks and for whom more weight reduction is clinically indicated. Zepbound’s maintenance doses are 5, 10 and 15 mg. A higher dose also brings the gut reactions back, so the log matters more than the request.

    Does a plateau mean the medication has stopped working?

    No. The drug level at a stable dose is steady week to week, and the trials kept people at the maintenance dose for a full year while the curve flattened. A plateau is the body arriving at the weight it will now defend, with the medication still holding appetite down. In the Wegovy trial that switched people to placebo after 20 weeks, weight climbed back, which is the opposite of a medication that has stopped.

    Sources (6)
    • Wegovy (semaglutide) injection, Prescribing Information. Novo Nordisk / FDA, revised June 2026.
    • Zepbound (tirzepatide) injection, Prescribing Information. Eli Lilly, revised August 2026.
    • Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
    • Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022.
    • Adaptive thermogenesis after moderate weight loss: magnitude and methodological issues. European Journal of Nutrition, 2021.
    • Does adaptive thermogenesis occur after weight loss in adults? A systematic review. British Journal of Nutrition, 2022.

    Reviewed by the GLP-1 SOS editorial team · Education, not medical advice · Talk to your prescriber about your dose and your symptoms.

  • How long before a GLP-1 starts working (appetite and weight)?

    How long before a GLP-1 starts working (appetite and weight)?

    The short answer

    Appetite usually changes first, often within the first few weeks, and the weight follows more slowly. The first month is a starting dose, not a treatment dose: the labeled schedules step up every four weeks, and the drug level takes about four to five weeks to settle after each step. Expect a slow start, then a steady slope.

    At GLP-1 SOS, “it has been three weeks and nothing is happening” is the message our support desk reads most often in a customer’s first month. Here is the timeline the labels and the trials actually describe.

    The real timeline

    Three phases, not one

    1

    Weeks 1 to 4: starting dose

    Appetite shifts; the scale barely moves. This dose is testing your gut, not your weight.

    2

    Months 2 to 4: stepping up

    Each step needs about five weeks to settle. A steady slope begins.

    3

    Month 4 onward: treatment dose

    Most trial weight loss accrued here, across a year, then flattened.

    What is actually happening

    A GLP-1 medication works in two places. In the brain it acts on the regions that regulate appetite; the Wegovy prescribing information says its weight effect is likely mediated by affecting appetite. In the stomach it slows how fast food empties, so a small meal stays with you longer. Both effects begin with the first injection, so fullness arrives sooner and food takes up less of your thoughts in the first weeks, before the scale has moved much.

    The first month is a titration dose. Wegovy starts at 0.25 mg once weekly for weeks 1 to 4, then 0.5 mg, 1 mg and 1.7 mg for four weeks each, with the maintenance dose of 1.7 mg or 2.4 mg from week 17. Zepbound starts at 2.5 mg for four weeks, a dose the label describes as for treatment initiation and not approved for maintenance, then 5 mg, with further 2.5 mg steps after at least four weeks on each. Those early doses exist to let the gut adapt, not to move weight.

    Lab note

    The first month tests your gut, not your weight.

    Then there is the drug level itself. Semaglutide has a half-life of about one week, and its prescribing information states that steady-state exposure is reached after four to five weeks of once-weekly injections. Tirzepatide’s label puts steady state at four weeks. So each dose step is a five-week experiment, and for most of it the level is still climbing. Two shots at a new dose tell you almost nothing.

    The trials set the realistic timeline. STEP 1 ran 68 weeks: 16 weeks of escalation, then 52 weeks at 2.4 mg, for an average loss of 14.9 percent of body weight against 2.4 percent on placebo. SURMOUNT-1 ran 72 weeks with up to 20 weeks of escalation, for average losses of 15 to 20.9 percent against 3.1 percent. Most of that weight came off across the year after escalation, on a steady slope that flattened toward the end.

    What the trials measured

    The numbers behind the timeline

    68 weeks

    STEP 1 trial length: 14.9% average loss on Wegovy 2.4 mg vs 2.4% placebo

    72 weeks

    SURMOUNT-1 trial length: 15% to 20.9% average loss on Zepbound vs 3.1%

    4 to 5 weeks

    for once-weekly semaglutide to reach a steady level after each dose step

    Sources: Wegovy and Ozempic Prescribing Information, 2026; STEP 1, NEJM 2021; SURMOUNT-1, NEJM 2022.

    What to do

    1. Judge appetite, not the scale, in month one. Notice fullness arriving sooner, fewer snacks, a smaller plate left unfinished, and write it down. That is the medication working at a dose meant to test your gut, not your weight.
    2. Weigh once a week, same morning. Daily weights swing with water, salt and stool on a slowed gut. One weekly number, before breakfast and after the bathroom, is the only line worth reading.
    3. Put your schedule on the calendar. Ask your prescriber which dose you are on, when the next step is due, and which dose counts as your maintenance dose. You cannot judge a dose you have not reached.
    4. Give every step five weeks. The drug level is still climbing for most of that time. Unless side effects are the problem, do not ask for a change before a step has had its five weeks.
    5. Eat like the appetite change is real. Protein first, small meals, stop at satisfied. The weight comes from the calories the appetite change removes; eating through the fullness signal removes nothing.
    6. Track what the scale cannot see. A waist measurement once a month, how one specific pair of pants fits, evening hunger on a 1 to 5 scale. These move before the weight does.
    7. Bring the log if a maintenance dose has done nothing. After a reasonable run at a maintenance dose with no change in appetite or weight, take the weekly weights and the appetite notes to your prescriber. Response varies between people, and a longer hold, the next step, or a different medication are all normal things to discuss.
    GLP-1 SOS support team

    From our support desk at GLP-1 SOS

    If you wrote to us tonight saying it has been three weeks and nothing has changed, here is what we would say.

    Three weeks in, most people are still on the starting dose, and the level from that dose has not even settled yet. So we would ask two things. Has anything changed about hunger: fullness arriving sooner, fewer snacks, food on your mind less? If yes, the medication is doing what the first month is for. And when is your next step due? The labels move every four weeks, and each step needs about five weeks before the level is steady. Weigh once a week, same morning, and write the appetite notes next to the number. If a full maintenance dose has run its course with no change at all, that log is what your prescriber needs to see. Nothing to buy for this one. Time is the ingredient.

    We answer real questions from real people every day. Write to us if yours is not here.

    Reading month one

    What to expect, and what is not a fault

    What to expect

    • Fullness arriving sooner
    • Fewer snacks without trying
    • Food on your mind less
    • Small weight change on a starting dose
    • A steady slope after the steps

    Not a sign it is failing

    • A flat scale in weeks 1 to 4
    • Daily weights that swing
    • Two shots at a new dose, no change
    • Slower loss than a friend on another dose
    • Hunger returning the day before the shot

    Judge a step after five weeks, not five days.

    When to call your doctor

    Call your prescriber the same day if:

    • You are vomiting and cannot keep liquids down
    • You have severe stomach pain that does not ease
    • You feel faint when you stand
    • You have not been able to eat or drink normally for more than a day
    • Your urine is dark and scarce
    • You take insulin or a sulfonylurea and feel shaky or confused
    • Your mood drops in a way that worries you

    A slow start is normal. Feeling sick every day is not.

    GLP-1 SOS

    From the people behind the Lab

    You do not have to figure this out alone.

    GLP-1 SOS is the daily companion made for life on a GLP-1. Plain answers like this one, a support team that replies to real questions from real people, and daily formulas like GLP-1 SOS Daily Gut Relief, designed around the side effects that come with the medication. The GLP-1 Lab is our free education arm: no login, no paywall, no hype. Side effects are part of the road. Suffering through them is not.

    Meet GLP-1 SOS

    Questions people also ask

    How fast does Ozempic or Wegovy suppress appetite?

    For many people, within the first few weeks at the starting dose. The medication acts on appetite regions of the brain and slows the stomach from the first injection, so fullness arrives sooner and food noise quiets before the weight changes. Appetite is the earliest signal that the medication is working, and a flat scale in month one does not contradict it.

    Why am I not losing weight on 0.25 mg of semaglutide or 2.5 mg of Zepbound?

    Because those are starting doses. The Wegovy label schedules 0.25 mg for weeks 1 to 4 to reduce gut side effects before stepping up, and the Zepbound label says 2.5 mg is for treatment initiation and is not approved as a maintenance dose. Weight in the trials was measured after a full escalation and a year at the maintenance dose. Judge the dose you are on by appetite, and let the schedule do its job.

    Does Zepbound work faster than Wegovy?

    Neither label promises a faster start. Both use four-week steps, semaglutide reaches a steady level in four to five weeks per step and tirzepatide in four, and both are still starting doses in month one. SURMOUNT-1 ran 72 weeks and STEP 1 ran 68, and in both the weight came off over the whole year rather than the first month. The realistic difference in the early weeks is small; the schedule matters more than the molecule.

    How much weight should I lose in the first month on a GLP-1?

    No label sets a monthly target, and the first month is a starting dose in both schedules, so many people see little change on the scale while appetite is already shifting. The trial averages of 14.9 percent in STEP 1 and 15 to 20.9 percent in SURMOUNT-1 were measured at 68 and 72 weeks. A steady slope that begins once you reach a treatment dose is the realistic picture.

    Sources (5)
    • Wegovy (semaglutide) injection, Prescribing Information. Novo Nordisk / FDA, revised June 2026.
    • Zepbound (tirzepatide) injection, Prescribing Information. Eli Lilly, revised August 2026.
    • Ozempic (semaglutide) injection, Prescribing Information. Novo Nordisk, revised May 2026.
    • Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
    • Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022.

    Reviewed by the GLP-1 SOS editorial team · Education, not medical advice · Talk to your prescriber about your dose and your symptoms.